New drug 3D185 tested in patients with advanced cancers
NCT ID NCT04221204
First seen Mar 29, 2026 · Last updated May 25, 2026 · Updated 7 times
Summary
This early-phase study tests a new drug called 3D185 in adults with advanced solid tumors who have no standard treatment left. The main goal is to check the drug's safety and how the body processes it. A small number of participants (42) will receive the drug to see if it can help control their cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR, ADULT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Sarcoma Oncolog Research Center
Santa Monica, California, 90403, United States
-
Shanghai East Hospital
Shanghai, China
Conditions
Explore the condition pages connected to this study.